foxo4-dri senolytic peptide 2023 2024

doi: 10.1159/000475432 94 DenizNDolcenHaradaBHeCConzenSD Size:5 pcs https://cdn2.psychologytoday.com/assets/styles/manual_crop_1_1_1200x1200/public/teaser_image/blog_entry/2026-08/peptides.png.jpg?itok=XXXkg1nB Epitalon - Wikipedia Horse Health

Senolytics: charting a new course or enhancing existing anti-tumor therapies? | Cellular Oncology

Senolytics: charting a new course or enhancing existing anti-tumor therapies? | Cellular Oncology

4.8 / 5 · 22 reviews

USD20.46

Computational design of peptide targeting FOXO4. a, Domains of FOXO4

Computational design of peptide targeting FOXO4. a, Domains of FOXO4

4.0 / 5 · 14 reviews

USD22.47

Targeting the FOXO4-p53 axis by retro-inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline | Naunyn-Schmiedeberg's Archives of Pharmacology

Targeting the FOXO4-p53 axis by retro-inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline | Naunyn-Schmiedeberg's Archives of Pharmacology

4.9 / 5 · 9 reviews

USD27.72

Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells

Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells

4.9 / 5 · 30 reviews

USD25.43

Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis

Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis

4.6 / 5 · 20 reviews

USD28.95

Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment

Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment

4.5 / 5 · 13 reviews

USD21.71

Development of a novel senolytic by precise disruption of FOXO4-p53 complex

Development of a novel senolytic by precise disruption of FOXO4-p53 complex

4.6 / 5 · 27 reviews

USD26.40

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI

5.0 / 5 · 26 reviews

USD22.23

Frontiers

Frontiers

4.9 / 5 · 22 reviews

USD28.06

FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells

FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells

4.8 / 5 · 10 reviews

USD24.11

Cellular Aging and Senescence in Cancer: A Holistic Review of Cellular Fate Determinants

Cellular Aging and Senescence in Cancer: A Holistic Review of Cellular Fate Determinants

4.3 / 5 · 13 reviews

USD26.05

FOXO4 as a Redox-Sensitive Regulator of Antioxidant Defense and Cellular Senescence: Cysteine-Based Signaling, p53 Interaction, and Therapeutic Targeting

FOXO4 as a Redox-Sensitive Regulator of Antioxidant Defense and Cellular Senescence: Cysteine-Based Signaling, p53 Interaction, and Therapeutic Targeting

4.7 / 5 · 23 reviews

USD29.13

Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis

Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis

4.6 / 5 · 18 reviews

USD22.52

Frontiers

Frontiers

4.3 / 5 · 23 reviews

USD27.41

FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway

FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway

4.4 / 5 · 22 reviews

USD20.02

FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation

FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation

4.2 / 5 · 29 reviews

USD22.65

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI

4.0 / 5 · 12 reviews

USD29.19

FOXO4-DRI

FOXO4-DRI

4.2 / 5 · 16 reviews

USD24.68

FOXO4-DRI FOXO4/p53 Peptide – Peptagon

FOXO4-DRI FOXO4/p53 Peptide – Peptagon

4.3 / 5 · 25 reviews

USD23.49

FOXO4-DRI

FOXO4-DRI

4.9 / 5 · 5 reviews

USD21.16

Frequently Asked Questions for foxo4-dri senolytic peptide 2023 2024 Senolytics: charting a new course or enhancing existing anti-tumor therapies? | Cellular Oncology

What should I check about requirements or limitations before purchasing?

Check whether a stated limit affects the quantity or scope you expect. Ask whether a claimed feature depends on an additional selection at checkout.

What should I recheck when returning to an old shopping cart?

Check whether your saved contact details are still appropriate. Confirm the currency shown in the final total.

What should I check before accepting a suggested substitute?

Compare the substitute with your essential requirements. Confirm which optional additions remain compatible when relevant.